(Q73128670)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11053648%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Effect of consecutive lower-dose cisplatin in enhancement of 5-fluorouracil cytotoxicity in experimental tumor cells in vivo (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11053648%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

1 reference

H Araki

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11053648%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M Fukushima

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11053648%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Y Kamiyama

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11053648%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

T Shirasaka

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11053648%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

language of work or name

English

0 references

publication date

1 November 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11053648%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11053648%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

160

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11053648%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11053648%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

185-191

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11053648%20AND%20SRC:MED&resulttype=core&format=json

A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900583-8

7 January 2021

Thymidylate synthetase: mechanism of inhibition by 5-fluoro-2'-deoxyuridylate.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900583-8

7 January 2021

5-Fluoro-2′-Deoxyuridylate: Covalent Complex with Thymidylate Synthetase

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900583-8

7 January 2021

Superior clinical response and survival rates with initial bolus of cisplatin and 120 hour infusion of 5-fluorouracil before definitive therapy for locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900583-8

7 January 2021

Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900583-8

7 January 2021

Evaluation of high-dose cisplatin and 5-FU infusion as initial therapy in advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900583-8

7 January 2021

Response rates and survival in patients with head and neck cancer treated with a combination of cisplatin and 5-fluorouracil prior to radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900583-8

7 January 2021

Neoadjuvant chemotherapy with cisplatin and 5-fluorouracil, both in continuous 96-hour infusion, in the treatment of locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900583-8

7 January 2021

Randomized trial of neoadjuvant chemotherapy with cisplatin plus 5-fluorouracil, with or without leucovorin, in locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900583-8

7 January 2021

Low-dose continuous infusion 5-fluorouracil and cisplatin: phase II evaluation in advanced colorectal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900583-8

7 January 2021

Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900583-8

7 January 2021

Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900583-8

7 January 2021

Feasibility study on protracted infusional 5-fluorouracil and consecutive low-dose cisplatin for advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900583-8

7 January 2021

Continuous infusion of 5-fluorouracil plus low-dose cisplatin in tumor-bearing mice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900583-8

7 January 2021

Advanced pancreatic cancer successfully treated with continuous infusion of 5-fluorouracil and low-dose cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900583-8

7 January 2021

Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900583-8

7 January 2021

An early phase II study of oral S-1, a newly developed 5-fluorouracil derivative for advanced and recurrent gastrointestinal cancers. The S-1 Gastrointestinal Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900583-8

7 January 2021

Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900583-8

7 January 2021

Comparison of folylpolyglutamate hydrolases of mouse liver, kidney, muscle and brain

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900583-8

7 January 2021

Regulation of 5-methyltetrahydrofolate: homocysteine methyltransferase activity by methionine, vitamin B12, and folate in cultured baby hamster kidney cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900583-8

7 January 2021

10.1016/S0304-3835(00)00583-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11053648%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference